Related Experiment Videos

Chemotherapy for endocrine resistant cancer of the prostate

M A Eisenberger¹

¹Department of Medicine, University of Maryland, Baltimore.

Progress in Clinical and Biological Research

|January 1, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala Variant.

The Prostate·2025

Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Serial blood-based analysis of AR-V7 in men with advanced prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer.

Prostate cancer and prostatic diseases·2013

See all related articles